Predilife SA operates as a medical technology company. The firm develops and offers software that estimates the risk of breast cancer. Its product includes MammoRisk, which enables the risk of breast cancer to be evaluated. The company was founded by Stephane Ragusa in 2004 and is headquartered in Villejuif, France.